Armstrong Shaw Associates’s Corteva CTVA Stock Holding History

Armstrong Shaw Associates’s Portfolio CTVA Stock Details CTVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$302K	Sell	5,908 -238	-4%	-$12.6K	0.32%	36
2023 Q2	$352K	Sell	6,146 -1,602	-21%	-$93.5K	0.36%	35
2023 Q1	$467K	Hold	7,748	–	–	0.46%	32
2022 Q4	$455K	Sell	7,748 -177	-2%	-$11.2K	0.45%	31
2022 Q3	$453K	Hold	7,925	–	–	0.49%	29
2022 Q2	$429K	Hold	7,925	–	–	0.43%	33
2022 Q1	$456K	Sell	7,925 -827	-9%	-$42.3K	0.38%	33
2021 Q4	$414K	Sell	8,752 -449	-5%	-$20.4K	0.34%	35
2021 Q3	$387K	Hold	9,201	–	–	0.34%	35
2021 Q2	$408K	Sell	9,201 -262	-3%	-$12.1K	0.35%	35
2021 Q1	$441K	Sell	9,463 -3,368	-26%	-$149K	0.4%	35
2020 Q4	$497K	Sell	12,831 -205	-2%	-$7.33K	0.49%	32
2020 Q3	$376K	Hold	13,036	–	–	0.44%	32
2020 Q2	$349K	Sell	13,036 -3,249	-20%	-$84.5K	0.43%	35
2020 Q1	$383K	Sell	16,285 -261	-2%	-$7.18K	0.49%	36
2019 Q4	$489K	Sell	16,546 -4,725	-22%	-$125K	0.43%	36
2019 Q3	$596K	Sell	21,271 -256	-1%	-$7.4K	0.54%	35
2019 Q2	$637K	Buy	+21,527	New	+$579K	0.58%	35

Other funds holding CTVA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

IFP

Independent Franchise Partners London, United Kingdom $14.3B AUM 3.49% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Armstrong Shaw Associates's CTVA Position: Q3 2023 in Review

Armstrong Shaw Associates reduced its Corteva (CTVA) stake by 3.9% in Q3 2023, selling an estimated $12.6K and leaving 5,908 shares worth $302K. The position accounts for 0.32% of the portfolio, ranked #36.

Armstrong Shaw Associates first reported a position in CTVA in Q2 2019 and has held it in 18 quarters since. The position peaked at $637K in Q2 2019. 1,194 funds tracked by Wall St. Rank hold CTVA as of Q3 2023.

Armstrong Shaw Associates held 5,908 shares of Corteva worth $302K as of Q3 2023.
Armstrong Shaw Associates sold 238 Corteva shares in Q3 2023, an estimated $12.6K.
Corteva made up 0.32% of Armstrong Shaw Associates's portfolio in Q3 2023, its #36 holding.
Armstrong Shaw Associates first reported a position in Corteva in Q2 2019 and has held it in 18 quarters since.
Armstrong Shaw Associates's Corteva position peaked at $637K in Q2 2019.
1,194 funds tracked by Wall St. Rank held Corteva as of Q3 2023.

Based on Armstrong Shaw Associates's 13F filing for Q3 2023, filed 13 Oct 2023.